Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.66 is 94% above its 5-year average of -25.82, near the high end of its 5-year range (-74.01–-1.16).
0.00% above its 12-month average of -1.66.
Reported quarterly EPS; no daily interpolation. Q4 FY2026 (2026-06-30): 0.00.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.66
EARNINGS PER SHARE (EPS) AVG TTM
-1.66
EARNINGS PER SHARE (EPS) AVG 3Y
-2.82
EARNINGS PER SHARE (EPS) AVG 5Y
-25.82
EARNINGS PER SHARE (EPS) AVG 10Y
-135674.49
EARNINGS PER SHARE (EPS) AVG 15Y
-3017.58
EARNINGS PER SHARE (EPS) AVG 20Y
-7401.46
CURRENT VS TTM AVG
+0.00%
CURRENT VS 3Y AVG
+41.19%
CURRENT VS 5Y AVG
+93.57%
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
+99.94%
CURRENT VS 20Y AVG
+99.98%
Aytu BioPharma, Inc.
Market Cap
$22.00M
Earnings Per Share (EPS)
-1.66
TTM Avg
-1.66
3Y Avg
-2.82
5Y Avg
-25.82
Market Cap
$21.29M
Earnings Per Share (EPS)
-0.89
TTM Avg
-2.16
3Y Avg
-1.83
5Y Avg
-1.83
Market Cap
$24.54M
Earnings Per Share (EPS)
-4.34
TTM Avg
-3.52
3Y Avg
-3.45
5Y Avg
-7.67
Market Cap
$24.65M
Earnings Per Share (EPS)
N/A
TTM Avg
22.45
3Y Avg
9.70
5Y Avg
5.59
Market Cap
$18.54M
Earnings Per Share (EPS)
-0.66
TTM Avg
-0.90
3Y Avg
-9.28
5Y Avg
-9.88
Market Cap
$18.77M
Earnings Per Share (EPS)
-0.25
TTM Avg
-0.29
3Y Avg
-0.28
5Y Avg
-0.20
Market Cap
$25.61M
Earnings Per Share (EPS)
-0.29
TTM Avg
-0.41
3Y Avg
-1.95
5Y Avg
-2.99
Market Cap
$16.41M
Earnings Per Share (EPS)
-3.73
TTM Avg
-46.49
3Y Avg
-194.14
5Y Avg
-195.03
Market Cap
$17.24M
Earnings Per Share (EPS)
-0.21
TTM Avg
-0.22
3Y Avg
-0.25
5Y Avg
-0.30
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aytu BioPharma, Inc. (AYTU) | $22.00M | -1.66 | -1.66 | -2.82 | -25.82 |
| Actuate Therapeutics Inc (ACTU)vs › | $21.29M | -0.89 | -2.16 | -1.83 | -1.83 |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.54M | -4.34 | -3.52 | -3.45 | -7.67 |
| Kyntra Bio, Inc. (KYNB)vs › | $24.65M | N/A | 22.45 | 9.70 | 5.59 |
| Cosmos Health Inc. (COSM)vs › | $18.54M | -0.66 | -0.90 | -9.28 | -9.88 |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | -0.25 | -0.29 | -0.28 | -0.20 |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.61M | -0.29 | -0.41 | -1.95 | -2.99 |
| Bionano Genomics, Inc. (BNGO)vs › | $16.41M | -3.73 | -46.49 | -194.14 | -195.03 |
| Dyadic International, Inc. (DYAI)vs › | $17.24M | -0.21 | -0.22 | -0.25 | -0.30 |
| GridAI Technologies Corp. (GRDX)vs › | $27.31M | -4.31 | -4.75 | -350.99 | -43000.60 |
Trailing EPS (TTM)
$-1.66
Forward EPS (Est.)
$-0.62
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-06-30 | -1.16 |
| 2025-06-30 | -2.16 |
| 2024-06-30 | -2.86 |
| 2023-06-30 | -5.11 |
| 2022-06-30 | -74.01 |
| 2021-06-30 | -69.60 |
| 2020-06-30 | -60.20 |
| 2019-06-30 | -1210.28 |
| 2018-06-30 | -3061.23 |
| 2017-06-30 | -193194.38 |
| 2016-06-30 | -1294738.36 |
| 2015-06-30 | -551671.71 |
| 2014-08-31 | -619854.44 |
| 2013-08-31 | -7164.75 |
| 2012-08-31 | -7459.37 |
| 2011-08-31 | -17100.25 |
| 2010-08-31 | -10045.00 |
| 2009-08-31 | -11778.80 |
| 2008-08-31 | -11434.60 |
| 2007-08-31 | -48954.00 |
